The Novel Multifunctional, Iron-Chelating Drugs M30 and HLA20 Protect Pancreatic β-Cell Lines from Oxidative Stress Damage

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2010-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.109.164269PMID 20237072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotective and neuritogenic activities of novel multimodal iron‐chelating drugs in motor‐neuron‐like NSC‐34 cells and transgenic mouse model of amyotrophic lateral sclerosis

  2009cited by this paper
• Protection of insulin-producing cells against toxicity of dexamethasone by catalase overexpression.

  2009cited by this paper
• Protection against Hydrogen Peroxide-Mediated Cytotoxicity in Friedreich's Ataxia Fibroblasts Using Novel Iron Chelators of the 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone Class

  2008cited by this paper
• Oxidative stress: the vulnerable beta-cell.

  2008influential reference
• TVP1022 and Propargylamine Protect Neonatal Rat Ventricular Myocytes Against Doxorubicin-Induced and Serum Starvation-Induced Cardiotoxicity

  2008cited by this paper
• Diabetes associated cell stress and dysfunction: role of mitochondrial and non‐mitochondrial ROS production and activity

  2007cited by this paper
• Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease 1

  2007cited by this paper
• N-acetylcysteine Prevents Nitrosative Stress-Associated Depression of Blood Pressure and Heart Rate in Streptozotocin Diabetic Rats

  2006cited by this paper
• The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer

  2005cited by this paper
• Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletion

  2005cited by this paper
• Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

  2005influential reference
• Protective effect of puerariae radix on oxidative stress induced by hydrogen peroxide and streptozotocin.

  2005cited by this paper
• Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition

  2005influential reference
• Iron Metabolism and the IRE/IRP Regulatory System: An Update

  2004cited by this paper
• Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells.

  2004cited by this paper
• Regulation of protein kinase C by the anti‐Parkinson drug, MAO‐B inhibitor, rasagiline and its derivatives, in vivo

  2004influential reference
• Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members

  2004influential reference
• Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases

  2004cited by this paper
• Are Oxidative StressActivated Signaling Pathways Mediators of Insulin Resistance and -Cell

  2003cited by this paper
• Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

  2003cited by this paper
• Free radicals in the physiological control of cell function.

  2002influential reference
• The anti-parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells

  2002cited by this paper
• Mitochondrial permeability transition mediates apoptosis induced by N‐methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, N‐propargyl‐1(R)‐aminoindan

  2002influential reference
• Molecular bases of cellular iron toxicity.

  2002cited by this paper
• Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

  2002cited by this paper
• Effects of intraperitoneally administered vitamin C on antioxidative defense mechanism in rats with diabetes induced by streptozotocin.

  2001cited by this paper
• Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes.

  2001cited by this paper
• Transfection‐enforced Bcl‐2 overexpression and an anti‐Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde‐3‐phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N‐methyl(R)salsolinol

  2001cited by this paper
• Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan.

  2001cited by this paper
• Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes.

  2000cited by this paper
• Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat.

  2000cited by this paper
• Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.

  1999cited by this paper
• The mitochondrial permeability transition pore and its role in cell death.

  1999cited by this paper
• Effect of superoxide dismutase, catalase, chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro.

  1999cited by this paper
• Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.

  1998cited by this paper
• Pancreatic β Cell–specific Expression of  Thioredoxin, an Antioxidative and Antiapoptotic Protein, Prevents Autoimmune and Streptozotocin-induced Diabetes

  1998cited by this paper
• Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells

  1997cited by this paper
• Toxicity of iron and hydrogen peroxide: the Fenton reaction.

  1995cited by this paper
• Cellular injury induced by oxidative stress is mediated through lysosomal damage.

  1995cited by this paper
• Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells.

  1990cited by this paper
• Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Department of Pharmacology

  1969cited by this paper

• The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

  2023cites this paper
• Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer’s disease

  2022cites this paper
• Investigation of 8-hydroxyquinoline by quantum-mechanical modeling and visible absorption spectroscopy

  2022cites this paper
• Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer's disease.

  2021cites this paper
• Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease

  2021cites this paper
• The Effects of Redox-Active Metal Ions and Amyloid-Degrading Enzymes on the Pathology of Alzheimer's Disease

  2021cites this paper
• The main targets involved in neuroprotection for the treatment of Alzheimer's Disease and Parkinson Disease.

  2020cites this paper
• Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.

  2018cites this paper
• Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.

  2018cites this paper
• Human Butyrylcholinesterase complexed with N-Propargyliperidines

  2018cites this paper
• A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice

  2017cites this paper
• A study on the effect of ion chelating agent on Alzheimer disease

  2017cites this paper
• Multitarget Anti-Alzheimer Hybrid Compounds: Do They Work In Vivo?

  2017cites this paper
• Study of 5-azidomethyl-8-hydroxyquinoline structure by X-ray diffraction and HF–DFT computational methods

  2017cites this paper
• Inhibition of caspase-9 aggravates acute liver injury through suppression of cytoprotective autophagy

  2016cites this paper
• Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets

  2016cites this paper
• Molecular Mechanisms of Toxicity and Cell Damage by Chemicals in a Human Pancreatic Beta Cell Line, 1.1B4

  2016cites this paper
• M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus

  2016cites this paper
• Inhibition of caspase-9 aggravates acute liver injury through suppression of cytoprotective autophagy

  2016cites this paper
• Responses of GLP1-secreting L-cells to cytotoxicity resemble pancreatic β-cells but not α-cells.

  2015cites this paper
• Novel monoamine oxidase inhibitors: a patent review (2012 – 2014)

  2015cites this paper
• Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.

  2015cites this paper
• Brain catalase in the streptozotocin-rat model of sporadic Alzheimer’s disease treated with the iron chelator–monoamine oxidase inhibitor, M30

  2015cites this paper
• Calculation of Solubility of Oxyquinolinates

  2014cites this paper
• Iron: the hard player in diabetes pathophysiology

  2014cites this paper
• In Vitro Imaging of Trypanosoma cruzi Host Infection Systems for Evaluation of Compound Activity

  2014cites this paper
• Iron overload and glucose metabolism in subjects with β-thalassaemia major: an overview.

  2013cites this paper
• The impact of iron content in a diet high in fat, fructose, and salt on metabolic state and mineral status of rats

  2013cites this paper
• 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications

  2013influential citation
• From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease

  2012cites this paper
• Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential

  2012cites this paper
• Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism

  2012cites this paper
• Advances in iron chelation: an update

  2011cites this paper
• Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer’s disease: a tribute to Moussa Youdim

  2011cites this paper
• Role of Oxidant Scavengers in the Prevention of Ca2+ Homeostasis Disorders

  2010cites this paper